{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T04:55:41Z","timestamp":1784868941887,"version":"3.55.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,6]],"date-time":"2020-05-06T00:00:00Z","timestamp":1588723200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,5,6]],"date-time":"2020-05-06T00:00:00Z","timestamp":1588723200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005270","name":"Fujian Provincial Department of Science and Technology","doi-asserted-by":"crossref","award":["2018-ZQN-54"],"award-info":[{"award-number":["2018-ZQN-54"]}],"id":[{"id":"10.13039\/501100005270","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002855","name":"Ministry of Science and Technology of the People's Republic of China","doi-asserted-by":"crossref","award":["2017ZX10202201"],"award-info":[{"award-number":["2017ZX10202201"]}],"id":[{"id":"10.13039\/501100002855","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Qingzhong Medical Science Research Fund","award":["B17344"],"award-info":[{"award-number":["B17344"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["grant 81400711"],"award-info":[{"award-number":["grant 81400711"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Backgrounds<\/jats:title>\n                    <jats:p>There is a discrepancy between west and east on the relationship between non-alcoholic fatty liver disease (NAFLD) and chronic kidney disease (CKD). This study aimed to find out the possible reason for this and to clarify the association between NAFLD and CKD by analyzing two population-based datasets from the US and China.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Two health examination datasets from China and the US were used. CKD was defined as an estimated glomerular filtration rate (eGFR)\u2009&lt;\u200960\u2009ml\/min\/1.73m\n                      <jats:sup>2<\/jats:sup>\n                      or and\/or abnormal albuminuria and\/or overt proteinuria. Binary logistic regression was used to examine the association between NAFLD and CKD.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 60,965 participants were analyzed, including 11,844 from the US and 51,229 from China. The prevalence of NAFLD was 27.12% in the Chinese population and 36.08% in the US population (\n                      <jats:italic>p<\/jats:italic>\n                      \u00a0&lt;\u20090.001). The proportions of CKD and late stage CKD (stages 3\u20135) were higher in the US population than the Chinese one. NAFLD was independently associated with an increased risk of CKD in Chinese population, whereas in the US population, the NAFLD was not an independent risk factor of CKD. In subgroup analyses which excluded late stages CKD (stages 3\u20135), the risks of mild renal function decline became consistent: NAFLD was associated with early stages of CKD but not the late stages of CKD in both populations.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>NAFLD increased the risk of early stages of CKD in both Chinese and the US population. The conflicting results reported by previous studies might result from the different proportion of late stages of CKD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12876-020-01278-z","type":"journal-article","created":{"date-parts":[[2020,5,6]],"date-time":"2020-05-06T10:03:55Z","timestamp":1588759435000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Association between NAFLD and risk of prevalent chronic kidney disease: why there is a difference between east and west?"],"prefix":"10.1186","volume":"20","author":[{"given":"Min","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-fang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao-feng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-ying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su-mei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao-yang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-mu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Yue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Chu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan-ming","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue-yong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Hua","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-zhong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,6]]},"reference":[{"issue":"Suppl 1","key":"1278_CR1","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/liv.13643","volume":"38","author":"AR Araujo","year":"2018","unstructured":"Araujo AR, et al. Global epidemiology of non-alcoholic fatty liver disease\/non-alcoholic steatohepatitis: what we need in the future. Liver Int. 2018;38(Suppl 1):47\u201351.","journal-title":"Liver Int"},{"issue":"6","key":"1278_CR2","doi-asserted-by":"publisher","first-page":"430","DOI":"10.4093\/dmj.2017.41.6.430","volume":"41","author":"E Han","year":"2017","unstructured":"Han E, Lee YH. Non-alcoholic fatty liver disease: the emerging burden in Cardiometabolic and renal diseases. Diabetes Metab J. 2017;41(6):430\u20137.","journal-title":"Diabetes Metab J"},{"key":"1278_CR3","first-page":"9583790","volume":"2019","author":"D Wu","year":"2019","unstructured":"Wu D, et al. Nonalcoholic fatty liver disease aggravated the severity of acute pancreatitis in patients. Biomed Res Int. 2019;2019:9583790.","journal-title":"Biomed Res Int"},{"issue":"5","key":"1278_CR4","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1111\/apt.15163","volume":"49","author":"S Sookoian","year":"2019","unstructured":"Sookoian S, Pirola CJ. Review article: shared disease mechanisms between non-alcoholic fatty liver disease and metabolic syndrome \u2013 translating knowledge from systems biology to the bedside. Aliment Pharmacol Ther. 2019;49(5):516\u201327.","journal-title":"Aliment Pharmacol Ther"},{"issue":"31","key":"1278_CR5","doi-asserted-by":"publisher","first-page":"7006","DOI":"10.3748\/wjg.v22.i31.7006","volume":"22","author":"L Abenavoli","year":"2016","unstructured":"Abenavoli L, et al. Metabolic aspects of adult patients with nonalcoholic fatty liver disease. World J Gastroenterol. 2016;22(31):7006\u201316.","journal-title":"World J Gastroenterol"},{"issue":"4","key":"1278_CR6","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.jhep.2020.01.013","volume":"72","author":"CD Byrne","year":"2020","unstructured":"Byrne CD, Targher G. NAFLD as a driver of chronic kidney disease. J Hepatol. 2020;72(4):785\u2013801.","journal-title":"J Hepatol"},{"key":"1278_CR7","doi-asserted-by":"publisher","first-page":"2383508","DOI":"10.1155\/2019\/2383508","volume":"2019","author":"K Kumela Goro","year":"2019","unstructured":"Kumela Goro K, et al. Patient Awareness, Prevalence, and Risk Factors of Chronic Kidney Disease among Diabetes Mellitus and Hypertensive Patients at Jimma University Medical Center, Ethiopia. Biomed Res Int. 2019;2019:2383508.","journal-title":"Biomed Res Int"},{"issue":"4","key":"1278_CR8","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1053\/j.ajkd.2014.05.019","volume":"64","author":"G Targher","year":"2014","unstructured":"Targher G, Chonchol MB, Byrne CD. CKD and nonalcoholic fatty liver disease. Am J Kidney Dis. 2014;64(4):638\u201352.","journal-title":"Am J Kidney Dis"},{"key":"1278_CR9","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.metabol.2017.11.003","volume":"79","author":"A Mantovani","year":"2018","unstructured":"Mantovani A, et al. Nonalcoholic fatty liver disease increases risk of incident chronic kidney disease: a systematic review and meta-analysis. Metabolism. 2018;79:64\u201376.","journal-title":"Metabolism"},{"issue":"5","key":"1278_CR10","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1111\/liv.14419","volume":"40","author":"A Mantovani","year":"2020","unstructured":"Mantovani A, et al. PNPLA3 I148M gene variant and chronic kidney disease in type 2 diabetic patients with NAFLD: clinical and experimental findings. Liver Int. 2020;40(5):1130\u201341.","journal-title":"Liver Int"},{"issue":"1","key":"1278_CR11","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/liv.14251","volume":"40","author":"DQ Sun","year":"2020","unstructured":"Sun DQ, et al. PNPLA3 rs738409 is associated with renal glomerular and tubular injury in NAFLD patients with persistently normal ALT levels. Liver Int. 2020;40(1):107\u201319.","journal-title":"Liver Int"},{"issue":"8","key":"1278_CR12","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1111\/liv.14125","volume":"39","author":"RM Wilechansky","year":"2019","unstructured":"Wilechansky RM, et al. Relations of liver fat with prevalent and incident chronic kidney disease in the Framingham heart study: a secondary analysis. Liver Int. 2019;39(8):1535\u201344.","journal-title":"Liver Int"},{"issue":"3","key":"1278_CR13","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1097\/TP.0000000000000945","volume":"100","author":"AK Singal","year":"2016","unstructured":"Singal AK, et al. Nonalcoholic Steatohepatitis is the Most rapidly growing indication for simultaneous liver kidney transplantation in the United States. Transplantation. 2016;100(3):607\u201312.","journal-title":"Transplantation"},{"issue":"11","key":"1278_CR14","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1002\/lt.22382","volume":"17","author":"DD Houlihan","year":"2011","unstructured":"Houlihan DD, et al. Renal function in patients undergoing transplantation for nonalcoholic steatohepatitis cirrhosis: time to reconsider immunosuppression regimens? Liver Transpl. 2011;17(11):1292\u20138.","journal-title":"Liver Transpl"},{"issue":"5","key":"1278_CR15","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1159\/000343885","volume":"36","author":"JC Sirota","year":"2012","unstructured":"Sirota JC, et al. Association between nonalcoholic liver disease and chronic kidney disease: an ultrasound analysis from NHANES 1988-1994. Am J Nephrol. 2012;36(5):466\u201371.","journal-title":"Am J Nephrol"},{"issue":"2","key":"1278_CR16","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.atherosclerosis.2008.12.012","volume":"205","author":"KE Yun","year":"2009","unstructured":"Yun KE, et al. Elevated alanine aminotransferase levels predict mortality from cardiovascular disease and diabetes in Koreans. Atherosclerosis. 2009;205(2):533\u20137.","journal-title":"Atherosclerosis"},{"issue":"9","key":"1278_CR17","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","volume":"150","author":"AS Levey","year":"2009","unstructured":"Levey AS, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604\u201312.","journal-title":"Ann Intern Med"},{"issue":"5","key":"1278_CR18","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1053\/j.ajkd.2014.01.416","volume":"63","author":"LA Inker","year":"2014","unstructured":"Inker LA, et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am J Kidney Dis. 2014;63(5):713\u201335.","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"1278_CR19","doi-asserted-by":"publisher","first-page":"92","DOI":"10.11613\/BM.2012.010","volume":"22","author":"G Li","year":"2012","unstructured":"Li G, et al. Nonalcoholic fatty liver disease associated with impairment of kidney function in nondiabetes population. Biochem Med (Zagreb). 2012;22(1):92\u20139.","journal-title":"Biochem Med (Zagreb)"},{"issue":"7","key":"1278_CR20","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/j.acra.2018.08.019","volume":"26","author":"L Wang","year":"2019","unstructured":"Wang L. Ultrasound-diagnosed nonalcoholic fatty liver disease independently predicts a higher risk of developing diabetes mellitus in nonoverweight individuals. Acad Radiol. 2019;26(7):863\u20138.","journal-title":"Acad Radiol"},{"issue":"10","key":"1278_CR21","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.2169\/internalmedicine.50.5043","volume":"50","author":"Y Arase","year":"2011","unstructured":"Arase Y, et al. The development of chronic kidney disease in Japanese patients with non-alcoholic fatty liver disease. Intern Med. 2011;50(10):1081\u20137.","journal-title":"Intern Med"},{"issue":"4","key":"1278_CR22","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.metabol.2007.11.022","volume":"57","author":"Y Chang","year":"2008","unstructured":"Chang Y, et al. Nonalcoholic fatty liver disease predicts chronic kidney disease in nonhypertensive and nondiabetic Korean men. Metabolism. 2008;57(4):569\u201376.","journal-title":"Metabolism"},{"issue":"8","key":"1278_CR23","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1681\/ASN.2007101155","volume":"19","author":"G Targher","year":"2008","unstructured":"Targher G, et al. Increased risk of CKD among type 2 diabetics with nonalcoholic fatty liver disease. J Am Soc Nephrol. 2008;19(8):1564\u201370.","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"1278_CR24","first-page":"635","volume":"21","author":"M Chmielewski","year":"2008","unstructured":"Chmielewski M, et al. Lipid disorders in chronic kidney disease: reverse epidemiology and therapeutic approach. J Nephrol. 2008;21(5):635\u201344.","journal-title":"J Nephrol"},{"issue":"1","key":"1278_CR25","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1161\/HYPERTENSIONAHA.109.129841","volume":"54","author":"LC Plantinga","year":"2009","unstructured":"Plantinga LC, et al. Blood pressure control among persons without and with chronic kidney disease: US trends and risk factors 1999\u20132006. Hypertension. 2009;54(1):47\u201356.","journal-title":"Hypertension"},{"key":"1278_CR26","doi-asserted-by":"publisher","first-page":"146","DOI":"10.2741\/4585","volume":"23","author":"H Moradi","year":"2018","unstructured":"Moradi H, Vaziri ND. Molecular mechanisms of disorders of lipid metabolism in chronic kidney disease. Front Biosci (Landmark Ed). 2018;23:146\u201361.","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"9","key":"1278_CR27","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1007\/s11255-014-0796-9","volume":"46","author":"Y Li","year":"2014","unstructured":"Li Y, et al. Association between non-alcoholic fatty liver disease and chronic kidney disease in population with prediabetes or diabetes. Int Urol Nephrol. 2014;46(9):1785\u201391.","journal-title":"Int Urol Nephrol"},{"issue":"12","key":"1278_CR28","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.2215\/CJN.05050610","volume":"5","author":"G Targher","year":"2010","unstructured":"Targher G, et al. Relationship between kidney function and liver histology in subjects with nonalcoholic steatohepatitis. Clin J Am Soc Nephrol. 2010;5(12):2166\u201371.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"01","key":"1278_CR29","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/obr.12124","volume":"15 Suppl 1","author":"FY Zhai","year":"2014","unstructured":"Zhai FY, et al. Dynamics of the Chinese diet and the role of urbanicity, 1991\u20132011. Obes Rev. 2014;15 Suppl 1(01):16\u201326.","journal-title":"Obes Rev"},{"issue":"6","key":"1278_CR30","doi-asserted-by":"publisher","first-page":"4661","DOI":"10.3390\/nu7064661","volume":"7","author":"R Zhang","year":"2015","unstructured":"Zhang R, et al. The difference in nutrient intakes between Chinese and Mediterranean, Japanese and American Diets. Nutrients. 2015;7(6):4661\u201388.","journal-title":"Nutrients"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-020-01278-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-020-01278-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-020-01278-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,5]],"date-time":"2021-05-05T19:44:35Z","timestamp":1620243875000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-020-01278-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,6]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1278"],"URL":"https:\/\/doi.org\/10.1186\/s12876-020-01278-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.2.21313\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.2.21313\/v2","asserted-by":"object"}]},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,6]]},"assertion":[{"value":"30 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The research protocol of the study was approved by the ethics committee of Wenzhou People\u2019s Hospital. Written informed consent was obtained from all subjects in the original studies. All methods were performed in accordance with the Declaration of Helsinki regarding ethical standards for research involving human subjects.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"139"}}